Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Total Operating Expense | 116.13 | 55.61 | 35.81 | 27.55 |
Other Net | -0.14 | 0.03 | 0.03 | 0.10 |
Total Adjustmentsto Net Income | 0.00 | - | - | - |
Diluted Weighted Average Shares | 1.54 | 1.77 | 1.77 | 1.77 |
Depreciation/ Amortization | 0.12 | 0.10 | 0.11 | 0.13 |
Operating Income | 6.21 | 2.86 | 1.17 | 0.72 |
Net Income | 2.44 | 1.23 | 0.35 | 0.10 |
Income Availableto Com Excl Extra Ord | 2.44 | 1.23 | 0.35 | 0.10 |
Other Operating Expenses Total | 1.82 | 1.07 | 0.39 | 0.32 |
Net Income Before Taxes | 3.23 | 1.68 | 0.55 | 0.17 |
Minority Interest | -0.02 | 0.00 | 0.00 | 0.00 |
Net Income After Taxes | 2.46 | 1.23 | 0.35 | 0.10 |
Income Availableto Com Incl Extra Ord | 2.44 | 1.23 | 0.35 | 0.10 |
Costof Revenue Total | 110.68 | 53.34 | 34.69 | 26.56 |
Gross Profit | 11.66 | 5.14 | 2.29 | 1.71 |
Interest Inc( Exp) Net- Non- Op Total | -2.85 | -1.22 | -0.65 | -0.64 |
Unusual Expense( Income) | 0.00 | 0.00 | 0.00 | 0.00 |
Diluted Net Income | 2.44 | 1.23 | 0.35 | 0.10 |
Provisionfor Income Taxes | 0.77 | 0.44 | 0.20 | 0.07 |
period Type | - | - | - | - |
Net Income Before Extra Items | 2.44 | 1.23 | 0.35 | 0.10 |
Total Revenue | 122.34 | 58.48 | 36.98 | 28.27 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Revenue | 122.34 | 58.48 | 36.98 | 28.27 |
Selling/ General/ Admin Expenses Total | 3.51 | 1.10 | 0.62 | 0.54 |
Diluted Normalized EPS | 1.59 | 0.70 | 0.20 | 0.05 |
Diluted EPS Excluding Extra Ord Items | 1.59 | 0.70 | 0.20 | 0.05 |
Mono Pharmacare Dividend Mono Pharmacare Bonus Mono Pharmacare News Mono Pharmacare AGM Mono Pharmacare Rights Mono Pharmacare Splits Mono Pharmacare Board Meetings Mono Pharmacare Key Metrics Mono Pharmacare Shareholdings Mono Pharmacare Balance Sheet Mono Pharmacare Cashflow Mono Pharmacare Q1 Results Mono Pharmacare Q2 Results Mono Pharmacare Q3 Results Mono Pharmacare Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks